Bio-Gene Technology Ltd

Bio-Gene Technology gets positive test results against major rice field pest

The Flavocide™ trial site was in central Thailand, a major rice-growing region.

Brown plant hopper isolated on white background
The company aims to develop and commercialise insect control and management solutions

Bio-Gene Technology Limited (ASX:BGT) has received positive results from its Flavocide™ field trial against the serious rice pest, the brown planthopper.

An estimated A$3.7 billion is spent on rice insecticides globally with much of this directed towards control of planthoppers.

The results highlight the potential of Flavocide™ to be used in a major global food crop.

Flavocide™ superior to existing chemistry

In the field trial, Flavocide™ was shown to:

• Be effective against both nymphs and adult planthoppers and was superior to the existing chemistry used, which acted as positive controls for this trial;
• Exhibit repellency effects that would potentially assist in preventing re-infestation and virus transmission within the crop; and
• Have no observable impact on beneficial species (e.g. predatory mirids and spiders) present in the crop over the course of the trial - this would indicate that Flavocide™ may be compatible with integrated pest management programs in rice.

90% of the global rice crop is grown in Asia

Richard Jagger commented: “These are positive and encouraging results that demonstrate the potential of Flavocide™ for control of a major rice pest, particularly in Asia, and provides justification for further evaluation to fine tune dose rates and further demonstrate efficacy in a range of field conditions.

“Rice is the staple food of half of the world's population and more than 90% of the global rice crop is grown in Asia.”

More tests in Asia planned to attract commercial interest

From here the company plans to work with its collaborators to undergo further trials across Asia.

By creating additional positive data it intends to attract commercial interest from a number of companies that operate within this market.

Quick facts: Bio-Gene Technology Ltd

Price: $0.12

Market: ASX
Market Cap: $15.48 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Musgrave Minerals intersects high-grade gold at Lena and Mainland Prospects

Musgrave Minerals Ltd (ASX:MGV) managing director Rob Waugh updates Proactive Investors on high-grade gold intersected from drilling at the company’s flagship Cue Gold Project in Western Australia.   Both results are below the current JORC resource and highlight the potential to extend...

13 hours, 59 minutes ago

2 min read